Home

QuarStar Human All Exon Probes 4.0 (Heredity)

Home - >Products - Whole Exome Sequencing Probes

Data

More Comprehensive and Updated Coverage

At the design level, QuarStar Human All Exon Probes 4.0 (Heredity Version) selects core coding exonic regions from the latest versions of mainstream databases, achieving nearly 99.5% target design coverage.

 

Excluding the CNV backbone, the total target region is 41.05 Mb, with a probe-covered region of 45.58 Mb, resulting an optimized bait-to-target ratio of 1.11, ensuring comprehensive coverage while minimizing unnecessary probe redundancy and sequencing cost.

 

Table 1. QuarStar Human All Exon Probes 4.0 (Heredity Version) Database and Coverage

1

Outstanding Performance

Leveraging its proprietary high-throughput synthesis platform, Dynegene enables large-scale probe production together with iterative optimization of multiple probe design versions. AI-driven probe design further improves on-target rate and target coverage. In addition, a non-polarization boosting strategy combined with an unbiased probe amplification process ensures exceptionally high coverage uniformity. Furthermore, a unique double-stranded multi-level probe biotin labeling technology provides significantly higher labeling efficiency than conventional column-synthesized probe end-labeling methods, ensuring sufficient sequencing depth even for low-input samples and challenging variant regions.

 

/ Industry-Leading GC Bias Control

11

Figure 1: GC Bias Analysis

 

Regions with GC content from 18% to 86% maintain sequencing depth above 0.5× of the mean depth, while regions between 28% and 82% GC remain within 0.9–1.1× of the mean depth. Within the typical genomic GC range (35%–65%), sequencing depth is approximately equal to the mean depth.

 

As shown in Figure 1, sequencing depth remains stable across a wide GC content range, which is significantly superior to mainstream domestic and international competitors.

 

/ Higher On-Target Rate at High Coverage

 

figure2

 

Figure 2: Core Performance Metrics

· Coverage > 99.5%         · On-target rate ≈ 90%   

· 0.2× uniformity > 99%    · 0.5× uniformity ≈ 93%

· Consistent performance under single-plex and multiplex (12-plex) hybridization conditions

/ Precise Differential Depth Design

figure3

 

Figure 3: Differential Depth Statistics

Based on regional characteristics and detection complexity, differentiated sequencing depth is implemented to maximize data utilization.

· Single-plex: 8 Gb/sample

· 12-plex: 4 Gb/sample

· Effective depth of core exonic regions reaches 11.5× per Gb

(Data includes optional CNV and mitochondrial targets.)

 

/ Exceptional Uniformity

figure4

 

Figure 4: Fold-80 Statistics

· Core exon uniformity (0.5×) reaches 95.49%

· Fold-80 as low as 1.21

· Overall Fold-80 ranges between 1.3–1.4 under both single-plex and multiplex conditions

 

/ Superior Variant Detection Capability

figure5

 

Figure 5: F1 Score Statistics

Using the NA12878 reference standard library for capture sequencing:

· SNP F1 score > 99%

· Indel F1 score > 93.5%

 

Comprehensive Target Content

a)More Comprehensive Target Content

Based on the latest expert consensus, guideline documents, and published literature, QuarStar Human All Exon Probes 4.0 (Heredity Version) covers more than 40 high-frequency complex variant genes (including CNVs and large insertions/deletions) for full transcript coverage, aiming to improve detection rates of complex variants and rare diseases.

2

Figure 6: BRCA, DMD, SMAD3 Gene Coverage Comparison

 

b)Full-length mitochondrial genome coverage reaches 100%, with 0.5× uniformity also at 100% after deduplication.

 

3

Figure 7: Full Mitochondrial Genome Coverage

The panel also includes ancestry markers, pharmacogenomic loci (e.g., CYP2C19, CYP2D6, TPMT), and sample tracking SNPs to support diverse analyses.

 

Enhanced Detection of Challenging Regions

a)TERT Promoter Coverage

Sequencing depth of the TERT promoter exceeds 250×, surpassing panel average, with highly uniform coverage.

4

Figure 8: TERT Promoter Hotspot Coverage

b)Improved STR Region Capture

Highly repetitive STR regions are captured with superior performance. For example, MONO-27 and NR-21 repeats (27 T and 21 A repeats) show significantly better coverage than competitor products.

5

Figure 9: STR Loci Coverage Comparison

c)Improved Capture of High GC Regions

In extremely high-GC regions, such as the GCGR gene and MMP17 exon 1, Dynegene demonstrates significantly improved coverage over competitors.

 

6

Figure 10: GC-Rich Region Coverage Comparison

 

One-Stop CNV Detection

/ Ultra-High Uniformity Enables Reliable CNV Detection

 

figure6

 

Figure 11: Core Exon Uniformity and Fold-80 Parameters

 

The extremely high coverage uniformity and low GC bias of QuarStar Human All Exon Probes 4.0 (Heredity Version) provide stable read-depth signals across target regions, enabling reliable CNV detection from WES data. This performance may reduce the need for additional baseline reference construction, simplifying the CNV analysis workflow and improving analysis efficiency and stability.

 

/ High-Density CNV Backbone Probes for Robust Detection

8

Figure 12: Genome-Wide Coverage of Backbone Probes

Heterozygous SNP loci with stable copy numbers and high MAF were carefully selected across the genome. Loci deviating from reference populations were excluded using Hardy–Weinberg equilibrium testing, and regions in centromeres, telomeres, highly homologous sequences (e.g., pseudogenes), and highly polymorphic regions (e.g., HLA) were removed.

 

Over 68,000 SNP loci were included, covering ~8.25 Mb of genomic regions, evenly distributed across intergenic and intronic regions to achieve detection resolution up to 25 kb.

 

9

 

Figure 13: Chromosomal Coverage Depth of SNP Backbone Probes

 

Using the NA12878 standard sample for hybrid capture sequencing, analysis of SNP site depth across chromosomes (excluding chrY) shows a highly balanced median depth, fully ensuring the backbone regions serve as stable internal references.

10

Figure 14: CNV Analysis of Chromosome 7

Analysis using CNVkit (v0.9.12) showed CNV detection based on backbone probes is highly feasible and accurate.

Dynegene Next-Gen Synthesis: Powering Biotech Revolution With Nucleic Acids

Contact Us

Tel: 400-017-9077

Address: Floor 2, Building 5, No. 248 Guanghua Road, Minhang District, Shanghai

Email: info2@dynegene.com

Follow Us

Copyright © 2026 Shanghai Dynegene Technologies Co., Ltd.
All rights reserved.   

Website Map I Privacy Policy